Viridian Therapeutics, Inc./DE (VRDN) Gross profit
Viridian Therapeutics, Inc./DE (VRDN) annual gross profit history from SEC filings — each fiscal year as reported.
$929,000FY2016
| Fiscal year | Value | YoY |
|---|---|---|
| FY2016 | $929,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VRDN financial trends
VRDN RevenueVRDN Net incomeVRDN Net marginVRDN Gross marginVRDN Operating incomeVRDN Operating marginVRDN Operating cash flowVRDN Free cash flowVRDN Capital expendituresVRDN Return on equityVRDN Stock buybacksVRDN Dividends paidVRDN Total assetsVRDN Total liabilitiesVRDN Shareholders’ equityVRDN overview →